Arkolith/Insider Trading/FULC/Form 4

Sapir Alex

See Remarks, DirectorFulcrum Therapeutics, Inc. (FULC) · full profile →Form 4 · filed Mar 5, 2024
Net Buying
Open-Market Buys
$492K
Open-Market Sells
$0
Net Open-Market Flow
$492K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2024Buy(P)43K$11.35$492K43K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-025933) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML